The toxic side effects of an experimental cancer drug from Onyx Pharmaceuticals may outweigh its benefits for patients with a type of blood cancer, federal health regulators said Monday.
Related posts:
Apple to add 3,600 jobs at new $304M Texas campus
Android tablet numbers “lack transparency” despite rising popularity
Kerry Kennedy Car Crash: Trucker Rocco Scuilettin Charged With Leaving Scene Of Accident
Increasing blindness among Palestinian detainees in Israeli jails due to medical negligence | @Ufree...
How To Refuse an ID Checkpoint
Wash Post's Chris Cillizza Definitively Declares: Obama Is 'Cool'; Romney Is 'Not Cool'
Views: 0